WellPoint Increases Dividend by 30 Percent

  WellPoint Increases Dividend by 30 Percent

Business Wire

INDIANAPOLIS -- February 21, 2013

WellPoint, Inc. (NYSE: WLP) today announced that its Board of Directors
authorized an increase of approximately 30 percent in the Company’s
shareholder dividend and declared a $0.375 per share dividend for the first
quarter of 2013. This quarterly rate represents an annualized dividend of
$1.50 per share, which equates to a yield of approximately 2.4 percent based
on the Company's stock price at yesterday's close of trading on the New York
Stock Exchange. The first quarter dividend is payable on March 25, 2013, to
shareholders of record at the close of business on March 8, 2013. The Company
continues to expect a return of capital to shareholders of approximately two
billion dollars during 2013, between its share repurchase and dividend
programs, subject to Company and market conditions.

About WellPoint, Inc.

At WellPoint, we believe there is an important connection between our members’
health and well-being—and the value we bring our customers and shareholders.
So each day we work to improve the health of our members and their
communities. And, we can make a real difference since we have more than 36
million people in our affiliated health plans, and nearly 67 million people
served through our subsidiaries. As an independent licensee of the Blue Cross
and Blue Shield Association, WellPoint serves members as the Blue Cross
licensee for California; the Blue Cross and Blue Shield licensee for Colorado,
Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30
counties in the Kansas City area), Nevada, New Hampshire, New York (as the
Blue Cross Blue Shield licensee in 10 New York City metropolitan and
surrounding counties and as the Blue Cross or Blue Cross Blue Shield licensee
in selected upstate counties only), Ohio, Virginia (excluding the Northern
Virginia suburbs of Washington, D.C.), and Wisconsin. In a majority of these
service areas, WellPoint’s plans do business as Anthem Blue Cross, Anthem Blue
Cross and Blue Shield, Blue Cross and Blue Shield of Georgia and Empire Blue
Cross Blue Shield, or Empire Blue Cross (in the New York service areas).
WellPoint also serves customers throughout the country as UniCare and in
certain markets through our Amerigroup and CareMore subsidiaries. Our 1-800
CONTACTS, Inc. subsidiary offers customers online sales of contact lenses,
eyeglasses and other ocular products. Additional information about WellPoint
is available at www.wellpoint.com.


WellPoint and its representatives may from time to time make written and oral
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995 (PSLRA), including statements in this press
release, in presentations, filings with the Securities and Exchange
Commission, or SEC, reports to shareholders and in meetings with analysts and
investors. The projections referenced in this press release are
forward-looking and they are intended to be covered by the safe harbor for
“forward-looking statements” provided by PSLRA. Words such as “expect(s)”,
“feel(s)”, “believe(s)”, “will”, “may”, “anticipate(s)”, “intend”, “estimate”,
“project” and similar expressions are intended to identify forward-looking
statements, which generally are not historical in nature. These statements
include, but are not limited to, financial projections and estimates and their
underlying assumptions; statements regarding plans, objectives and
expectations with respect to future operations, products and services; and
statements regarding future performance. Such statements are subject to
certain risks and uncertainties, many of which are difficult to predict and
generally beyond our control, that could cause actual results to differ
materially from those expressed in, or implied or projected by, the
forward-looking information and statements. These risks and uncertainties
include: those discussed and identified in our public filings with the SEC;
increased government participation in, or regulation or taxation of, health
benefits and managed care operations, including, but not limited to, the
impact of the Patient Protection and Affordable Care Act and the Health Care
and Education Reconciliation Act of 2010; trends in health care costs and
utilization rates; our ability to secure sufficient premium rates including
regulatory approval for and implementation of such rates; our ability to
contract with providers consistent with past practice; our ability to
integrate and achieve expected synergies and operating efficiencies in the
AMERIGROUP Corporation and 1-800 CONTACTS, Inc. acquisitions within the
expected timeframes or at all and to successfully integrate our operations, as
such integrations may be more difficult, time consuming or costly than
expected, revenues following the transactions may be lower than expected and
operating costs, customer loss and business disruption, including, without
limitation, difficulties in maintaining relationships with employees,
customers, clients and suppliers, may be greater than expected following the
transactions; competitor pricing below market trends of increasing costs;
reduced enrollment, as well as a negative change in our health care product
mix; risks and uncertainties regarding Medicare and Medicaid programs,
including those related to non-compliance with the complex regulations imposed
thereon and funding risks with respect to revenue received from participation
therein; a downgrade in our financial strength ratings; litigation and
investigations targeted at our industry and our ability to resolve litigation
and investigations within estimates; medical malpractice or professional
liability claims or other risks related to health care services provided by
our subsidiaries; risks inherent in selling healthcare products in the
consumer retail market; our ability to repurchase shares of our common stock
and pay dividends on our common stock due to the adequacy of our cash flow and
earnings and other considerations; non-compliance by any party with the
Express Scripts, Inc. pharmacy benefit management services agreement, which
could result in financial penalties, our inability to meet customer demands,
and sanctions imposed by governmental entities, including the Centers for
Medicare and Medicaid Services; events that result in negative publicity for
us or the health benefits industry; failure to effectively maintain and
modernize our information systems and e-business organization and to maintain
good relationships with third party vendors for information system resources;
events that may negatively affect our licenses with the Blue Cross and Blue
Shield Association; possible impairment of the value of our intangible assets
if future results do not adequately support goodwill and other intangible
assets; intense competition to attract and retain employees; unauthorized
disclosure of member sensitive or confidential information; changes in the
economic and market conditions, as well as regulations that may negatively
affect our investment portfolios and liquidity; possible restrictions in the
payment of dividends by our subsidiaries and increases in required minimum
levels of capital and the potential negative effect from our substantial
amount of outstanding indebtedness; general risks associated with mergers and
acquisitions; various laws and provisions in our governing documents that may
prevent or discourage takeovers and business combinations; future public
health epidemics and catastrophes; and general economic downturns. Readers are
cautioned not to place undue reliance on these forward-looking statements that
speak only as of the date hereof. Except to the extent otherwise required by
federal securities law, we do not undertake any obligation to republish
revised forward-looking statements to reflect events or circumstances after
the date hereof or to reflect the occurrence of unanticipated events. Readers
are also urged to carefully review and consider the various disclosures in our
SEC reports.


Investor Relations
Doug Simpson, 212-476-1473
Kristin Binns, 917-697-7802
Press spacebar to pause and continue. Press esc to stop.